NCT01582477View on ClinicalTrials.gov

TAP-patients With Robotic Assisted Lap Prostatectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

July 31, 2012

Conditions
Postsurgical PainAnalgesiaProstatectomy
Interventions
DRUG

EXPAREL 20 mL

EXPAREL 266 mg (undiluted)

DRUG

EXPAREL 40 mL

EXPAREL 266 mg diluted with preservative-free 0.9% normal saline to 40 mL.

Trial Locations (1)

02135

Steward St. Elizabeth's, Brighton

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY